Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hyperlipidaemia
ADR ID BADD_A06050
ADR Hierarchy
14      Metabolism and nutrition disorders
14.08      Lipid metabolism disorders
14.08.03      Hyperlipidaemias NEC
14.08.03.001      Hyperlipidaemia
Description Conditions with excess LIPIDS in the blood. | Abnormally high level of lipids in blood. [MeSH]
MedDRA Code 10062060
MeSH ID D006949; D006951
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Hyperlipaemia | Hyperlipemia | Hyperlipidaemia NOS | Hyperlipidaemia secondary | Hyperlipidaemia, other and unspecified | Hyperlipidemia | Hyperlipoproteinemia | Other and unspecified hyperlipidaemia | Other and unspecified hyperlipidemia | Hyperlipidemia secondary | Hyperlipoproteinaemia | Hyperlipidaemia | Lipemia | Lipaemia | Hyperlipidemias | Hyperlipemias | Lipidemia | Lipidemias | Lipemias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00734Duloxetine--
BADD_D00735Duloxetine hydrochloride--
BADD_D00809Escitalopram--
BADD_D00831Estrogens--
BADD_D00837Eszopiclone--
BADD_D00857Etravirine--
BADD_D00858Everolimus0.002507%
BADD_D00870Febuxostat--
BADD_D00873Fenofibrate0.000059%
BADD_D00898Finasteride0.003020%
BADD_D00932Fluoxetine--
BADD_D00950Fluvoxamine--
BADD_D00951Fluvoxamine maleate--
BADD_D00961Fosamprenavir calcium--
BADD_D00974Fragmin--
BADD_D00981Gabapentin--
BADD_D00983Gadobenate dimeglumine--
BADD_D01022Gliclazide--
BADD_D01038Goserelin--
BADD_D01059Heparan sulfate--
BADD_D01060Heparin--
BADD_D01061Heparin sodium--
BADD_D01162Insulin detemir--
BADD_D01166Interferon alfa-2a--
BADD_D01211Isosorbide mononitrate--
BADD_D01213Isotretinoin0.005455%
BADD_D01230Ketoconazole--
BADD_D01245Lansoprazole--
BADD_D01252Leflunomide--
BADD_D01261Leuprolide monoacetate--
The 2th Page    First    Pre   2 3 4 5    Next   Last    Total 5 Pages